Internal Medicine, Medical Oncology · Tampa, FL
NPI
1104025592
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12902 Usf Magnolia Dr
Tampa, FL, 33612
Phone (813) 745-7208
Groups this clinician bills Medicare through
Medicare paid, 2024
$23K
268 services
Medicare patients, 2024
52
Average age 70
Drug cost, 2024
$3.1M
703 prescriptions
Company payments, 2025
$1,150
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph A Pidala was code 99215 (office e&m - established), 152 times for 44 patients. In total Joseph A Pidala billed 268 services in 11 codes, and Medicare paid $23K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 152 | 44 | $111.61 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 55 | 28 | $12.97 | $713 |
| 99215 Office E&M - Established | Office | 22 | 11 | $142.06 | $3,125 |
By year: 2022 $21K for 194 services; 2023 $19K for 179 services; 2024 $23K for 268 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph A Pidala prescribed most often to Medicare patients was Rezurock (Belumosudil Mesylate), with 90 prescriptions and refills. In total Joseph A Pidala wrote 703 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rezurock Belumosudil Mesylate | 90 | 90 | 11 | $2.6M |
| Acyclovir Generic | 59 | 97 | 21 | $1,224 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 45 | 63 | 16 | $294 |
| Oxycodone Hcl Generic | 38 | 38 | 11 | $449 |
| Prednisone Generic | 28 | 32 | Under 11 | $365 |
| Tacrolimus Generic | 22 | 35 | Under 11 | $3,895 |
| Sirolimus Generic | 20 | 26 | Under 11 | $11K |
| Zolpidem Tartrate Generic | 18 | 24 | Under 11 | $167 |
| Triamcinolone Acetonide Generic | 17 | 17 | Under 11 | $277 |
| Gabapentin Generic | 17 | 20 | Under 11 | $192 |
| Tramadol Hcl Generic | 16 | 16 | Under 11 | $161 |
| Lorazepam Generic | 15 | 15 | Under 11 | $35.88 |
| Rosuvastatin Calcium Generic | 15 | 27 | Under 11 | $123 |
| Jakafi Ruxolitinib Phosphate | 14 | 14 | Under 11 | $297K |
| Levothyroxine Sodium Generic | 13 | 25 | Under 11 | $124 |
Brand drugs: 165 claims; generic drugs: 538 claims; opioid claims: 72.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph A Pidala $1,150 ($1,150 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sanofi-Aventis U.S. LLC with $825.
| Company | Payments | Amount |
|---|---|---|
| Sanofi-Aventis U.S. LLC SNY | 3 | $825 |
| National Marrow Donor Program | 2 | $325 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.